Oncolytic adenovirus retargeted to Delta-EGFR induces selective antiglioma activity.
Piao Y, Jiang H, Alemany R, Krasnykh V, Marini FC, Xu J, Alonso MM, Conrad CA, Aldape KD, Gomez-Manzano C, Fueyo J.
Piao Y, et al.
Cancer Gene Ther. 2009 Mar;16(3):256-65. doi: 10.1038/cgt.2008.75. Epub 2008 Oct 17.
Cancer Gene Ther. 2009.
PMID: 18927600
Free PMC article.